Background The efficacy and safety of combining epidermal growth factor receptor tyrosine
kinase inhibitors (EGFR-TKIs) with whole-brain radiotherapy (WBRT) for treating brain …

Background To investigate the efficacy and safety of whole brain radiotherapy (WBRT)
combined with epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) versus …

e19060 Background: NSCLC accounts for 85%-90% of lung cancers, in which brain
metastases (BMs) occur in 20–40% of all NSCLC cases. WBRT is the standard treatment for …

Introduction. Brain metastases (BMs) are common in non‐small‐cell lung cancer (NSCLC),
which leads to a poor prognosis. As the two most effective strategies available, the use of …

Background: The role of radiotherapy (RT) combined with epidermal growth factor receptor
tyrosine kinase inhibitors (EGFR-TKIs) in non-small cell lung cancer (NSCLC) patients with …

Introduction: Traditionally, brain metastases have been treated with stereotactic radiosurgery
(SRS), whole-brain radiation (WBRT), and/or surgical resection. Non-small cell lung cancers …

Simple Summary Radiotherapy, in the form of either whole-brain radiotherapy (WBRT) or
stereotactic radiosurgery (SRS), continues as the standard of care for patients of non-small …

Background: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) is
revolutionizing the management of brain metastases (BMs). This study was to explore the …

Background. To comprehensively assess the efficacy and safety of whole‐brain
radiotherapy (WBRT) combined with gefitinib/erlotinib for treatment of brain metastases (BM) …

Brain metastasis (BM) is the common complication of non‐small cell lung cancer (NSCLC)
with a poor prognosis and dismal survival rate. This update meta‐analysis aimed to derive a …